FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, particularly molecular biology and oncology. Described is a method for diagnosing ovarian cancer based on a group of microRNA genes by detecting methylation of at least one marker of four, characterized by that the markers of the system are genes miR-124a-3, miR-129-2, miR-193a and miR-107.
EFFECT: claimed method enables detecting ovarian cancer with high clinical sensitivity and specificity.
1 cl, 2 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORECASTING METASTASIS OF OVARIAN CANCER BASED ON MICRORNA GENE GROUP | 2016 |
|
RU2666911C2 |
| METHOD OF DIAGNOSIS OF CLEAR CELL RENAL CELL CARCINOMA AND METHOD FOR PREDICTION OF METASTASIS BASED ON MIRNA GENES GROUP | 2017 |
|
RU2683251C1 |
| METHOD FOR PREDICTION OF OVARIAN CANCER METASTASIS BASED ON SET OF GENES OF LONG NON-CODING RNA | 2023 |
|
RU2825782C1 |
| METHOD FOR DIAGNOSING OVARIAN CANCER BASED ON A SET OF GENES OF LONG NON-CODING RNA | 2021 |
|
RU2779550C1 |
| SYSTEM OF MARKERS BASED ON GROUP OF MICRORNA GENES FOR DIAGNOSTICS OF NON-SMALL-CELL LUNG CANCER INCLUDING EPIDERMOID CANCER AND ADENOCARCINOMA | 2012 |
|
RU2507268C1 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| METHOD FOR PREDICTING BREAST CANCER METASTASIS BASED ON SET OF LONG NON-CODING RNA GENES | 2022 |
|
RU2807480C1 |
| METHOD OF PREDICTING METASTASIS OF STOMACH CANCER TUMORS | 2021 |
|
RU2806432C2 |
| METHOD FOR DIAGNOSING BREAST CANCER BASED ON A SET OF LONG NON-CODING RNA GENES | 2022 |
|
RU2795976C1 |
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
